A Drug-Drug Interaction Study Between Fenofibric Acid and Efavirenz

Completed · Phase 1

Conditions studied: Healthy

In brief

Efavirenz is predominantly metabolized by cytochrome P450 (CYP) 2B6. Fenofibric Acid is an inhibitor of CYP2B6. This study will evaluate the effect of multiple doses of fenofibric acid at steady-state on the pharmacokinetics of single-dose efavirenz in healthy adult subjects.

Key facts

Study ID
NCT01472380
Run by
Mutual Pharmaceutical Company, Inc.
People needed
30
Starts
2011-11-01
Expected to finish
2012-01-01
Last updated by the study team
2012-08-01

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.